Technical Analysis for NVS - Novartis AG

Grade Last Price % Change Price Change
grade B 87.52 3.65% 3.08
NVS closed up 3.65 percent on Friday, May 24, 2019, on 1.71 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NVS trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%

Older signals for NVS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism, respiratory, and other medicines. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines, and blood testing and molecular diagnostics products to prevent the spread of infectious diseases. Its Consumer Health division consists of two divisions, including over-the-counter medicines that offer readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.
Biotechnology Health Pharmaceutical Industry Pharmaceuticals Drugs Infectious Diseases Medication Pharmacy Pharmaceutical Industry In China Pharmaceuticals Policy Neuroscience Active Pharmaceutical Ingredients Antibiotics Healthcare Products Over The Counter Drug Prescription Drug Alcon Contact Lenses Veterinary Products
Is NVS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 96.31
52 Week Low 72.3
Average Volume 2,754,035
200-Day Moving Average 86.4498
50-Day Moving Average 85.6908
20-Day Moving Average 82.3295
10-Day Moving Average 82.821
Average True Range 1.5676
ADX 20.05
+DI 44.9285
-DI 21.0254
Chandelier Exit (Long, 3 ATRs ) 83.7372
Chandelier Exit (Short, 3 ATRs ) 84.0428
Upper Bollinger Band 85.3793
Lower Bollinger Band 79.2797
Percent B (%b) 1.35
BandWidth 7.408766
MACD Line 0.1654
MACD Signal Line -0.6638
MACD Histogram 0.8292
Fundamentals Value
Market Cap 205.05 Billion
Num Shares 2.34 Billion
EPS 2.74
Price-to-Earnings (P/E) Ratio 31.94
Price-to-Sales 3.85
Price-to-Book 2.71
PEG Ratio 2.69
Dividend 2.72
Dividend Yield 3.11%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 90.70
Resistance 3 (R3) 90.65 89.55 90.17
Resistance 2 (R2) 89.55 88.74 89.57 89.99
Resistance 1 (R1) 88.53 88.24 89.04 88.58 89.82
Pivot Point 87.43 87.43 87.68 87.45 87.43
Support 1 (S1) 86.41 86.62 86.92 86.46 85.22
Support 2 (S2) 85.31 86.12 85.33 85.05
Support 3 (S3) 84.29 85.31 84.87
Support 4 (S4) 84.34